SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bo Didley who wrote (16)1/28/1999 3:22:00 PM
From: out_of_the_loop  Read Replies (1) of 5582
 
I have spoken with the company president of Gel Tech and a director of the GumTech company. They would not give me exact profit margins, but I was told they would make shareholders very happy.

The GUMM people are softpeddling this a bit to the media so that people do not think they are a hoax, since they are not big names in the pharmaceutical world.

They are trying to build the name ZICAM rather than the name of the stock or GumTech. This company will do very well with the product.

I mentioned specific problems I had with the GUMM press release (lame first line stating an agreement when PRODUCT IS ALREADY ON THE SHELVES, use of the word "homeopathic" rather than 'nonprescription' in the title and a big difference in tone between Geltech and Gumtech press releases).

The GUMM people were more concerned with an orderly procedure of things rather than a pump and dump.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext